Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

News & Events

-

Public Calendar: January 18-22, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title	Date	Location	Other FDA Participants	Non-FDA Participants	Subject
January 18-22, 2010
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs	1/20/10	Silver Spring, MD	Afia Asamoah	Lyle Beckwith, Doug Kantor, Jim Barnette, John Manthei (National Association of Convenience Stores)	Retail Segment of the Tobacco Industry
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs	1/21/10	Silver Spring, MD	Afia Asamoah, Ann Witt, Uros Djekic, Diane Maloney, Jane Axelrad, Tracey Forfa, Carolyn Becker, Michael Chappell	Aaron Lyss (American Association of Blood Banks ); Richard Carnevale (Animal Health Institute); Andrew Emmett (Biotechnology Information Organization); Gordon Johnston, Ashlee Konce (Generic Pharmaceutical Association); Jeffrey Francer, Alan Goldhammer, Jennifer Stotka (Pharmaceutical Research and Manufacturers of America); Bridget Rossiter Elis (Plasma Protein Therapeutics Association)	Transparency Listening Session
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs	1/21/10	Silver Spring, MD	N/A	Nav Singh, Vivian Riefberg, Nick Lovegrove (McKinsey and Company)	Collaboration with FDA
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health	1/19/10	Washington, D.C.	Vicki Seyfert-Margolis	Several participants from Private Industry, Government and Academia	PCAST National Nanotechonology Meeting
Russell Abbott, Deputy Commissioner for Administration	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget	1/21/10	Washington, DC	N/A	Several members of the American Health Lawyers Association	FDA and the Public Health
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health	1/18/10- 1/22/10	N/A	N/A	N/A	No Signicant Meetings
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition	1/20/10- 1/21/10	Phoeniz, Arizona	N/A	N/A	International Dairy Foods Association Forum
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine	1/22/10	Washington, D.C.	William Flynn, Cindy Burnsteel	Rich Carnevale (Animal Health Institute)	Veterinary issues of mutual interest
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research	1/20/10- 1/21/10	Jefferson, AR	N/A	N/A	U.S. Nutritional Phenotype Database Training Workshop
Ralph Tyler, J.D., Chief Counsel	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings
Lawrence Deyton, M.D., M.P.H., Director, Center for Tobacco Products	1/18/10- 1/22/10	N/A	N/A	N/A	No Significant Meetings

-

-